Dogan, I. Et Al. 2024. Efficacy of Lapatinib Plus Capecitabine After TDM-1 in HER2-Positive Metastatic Breast Cancer Patients. Indian Journal of Surgical Oncology , vol.15, no.3 , 489-494.

Dogan, I., Yıldız, A., Ahmed, M. A., & Vatansever, S., (2024). Efficacy of Lapatinib Plus Capecitabine After TDM-1 in HER2-Positive Metastatic Breast Cancer Patients. Indian Journal of Surgical Oncology , vol.15, no.3, 489-494.

Dogan, İzzet Et Al. "Efficacy of Lapatinib Plus Capecitabine After TDM-1 in HER2-Positive Metastatic Breast Cancer Patients," Indian Journal of Surgical Oncology , vol.15, no.3, 489-494, 2024

Dogan, İzzet Et Al. "Efficacy of Lapatinib Plus Capecitabine After TDM-1 in HER2-Positive Metastatic Breast Cancer Patients." Indian Journal of Surgical Oncology , vol.15, no.3, pp.489-494, 2024

Dogan, I. Et Al. (2024) . "Efficacy of Lapatinib Plus Capecitabine After TDM-1 in HER2-Positive Metastatic Breast Cancer Patients." Indian Journal of Surgical Oncology , vol.15, no.3, pp.489-494.

@article{article, author={İzzet DOĞAN Et Al. }, title={Efficacy of Lapatinib Plus Capecitabine After TDM-1 in HER2-Positive Metastatic Breast Cancer Patients}, journal={Indian Journal of Surgical Oncology}, year=2024, pages={489-494} }